Related Experiment Video
Updated: Jun 27, 2026

12:38
Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies
Published on: July 19, 2007
Will new regulations reverse the 'drop' in homeopathy?
The Journal of the Royal Society for the Promotion of Health
|December 9, 2008
Summary
Homeopathy lacks scientific evidence of effectiveness and safety. Patients face risks if they use homeopathy as a sole treatment instead of a complementary one.
Area of Science:
- Homeopathy
- Integrative Medicine
- Evidence-Based Practice
Background:
- Homeopathy's clinical effectiveness is debated due to a lack of scientific evidence.
- Despite claims of being 'harmless,' its use alongside conventional treatments is common.
- The potential benefits and risks of homeopathy require careful consideration.
Purpose of the Study:
- To critically evaluate the safety and efficacy of homeopathic treatments.
- To discuss the risks associated with using homeopathy as a standalone alternative therapy.
- To examine the regulatory landscape and public perception of homeopathy.
Main Methods:
- Literature review of studies on homeopathy's clinical effectiveness.
- Analysis of case studies and anecdotal reports regarding patient outcomes.
- Discussion of ethical considerations in promoting or using homeopathic remedies.
Main Results:
- Scientific evidence supporting homeopathy's effectiveness is largely absent.
- Patients may be misled into believing homeopathy is a viable alternative to conventional medicine.
- Over-reliance on homeopathy can lead to delayed or forgone essential medical care.
Conclusions:
- Homeopathy lacks robust scientific validation for clinical effectiveness.
- The perception of homeopathy as 'harmless' can be misleading, posing risks to patient health.
- Patients should be critically informed about the limitations of homeopathy and prioritize evidence-based treatments.
Related Concept Videos
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Drug Classes and Categories
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
